Literature DB >> 22071311

Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex.

Pauline Brummelman1, Margriet G A Sattler, Linda C Meiners, Martin F Elderson, Robin P F Dullaart, Gerrit van den Berg, Janneke Koerts, Oliver Tucha, Bruce H R Wolffenbuttel, Alfonsus C M van den Bergh, André P van Beek.   

Abstract

OBJECTIVE: The hippocampus and prefrontal cortex (PFC) are important for memory and executive functioning and are known to be sensitive to radiotherapy (RT). Radiation dosimetry relates radiation exposure to specific brain areas. The effects of various pituitary RT techniques were studied by relating detailed dosimetry of the hippocampus and PFC to cognitive performance.
METHODS: In this cross-sectional design, 75 non-functioning pituitary macroadenoma (NFA) patients (61±10 years) participated and were divided into irradiated (RT+, n=30) and non-irradiated (RT-, n=45) groups. The RT+ group (who all received 25 fractions of 1.8 Gy; total dose: 45 Gy) consisted of three RT technique groups: three-field technique, n=10; four-field technique, n=15; and five-field technique, n=5. Memory and executive functioning were assessed by standardized neuropsychological tests. A reconstruction of the dose distributions for the three RT techniques was made. The RT doses on 30, 50, and 70% of the volume of the left and right hippocampus and PFC were calculated.
RESULTS: Cognitive test performance was not different between the four groups, despite differences in radiation doses applied to the hippocampi and PFC. Age at RT, time since RT, and the use of thyroid hormone varied significantly between the groups; however, they were not related to cognitive performance.
CONCLUSION: This study showed that there were no significant differences on cognitive performance between the three-, four-, and five-field RT groups and the non-irradiated patient group. A dose-response relationship could not be established, even with a radiation dose that was higher on most of the volume of the hippocampus and PFC in case of a four-field RT technique compared with the three- and five-field RT techniques.

Entities:  

Mesh:

Year:  2011        PMID: 22071311     DOI: 10.1530/EJE-11-0749

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas.

Authors:  Beatriz Lecumberri; Javier Estrada; José García-Uría; Isabel Millán; Luis Felipe Pallardo; Luis Caballero; Tomás Lucas
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

2.  Long-term cognitive dysfunction after radiation therapy for primary brain tumors.

Authors:  Lene Haldbo-Classen; Ali Amidi; Lisa M Wu; Slavka Lukacova; Gorm von Oettingen; Hanne Gottrup; Robert Zachariae; Morten Høyer
Journal:  Acta Oncol       Date:  2019-02-13       Impact factor: 4.089

3.  Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly.

Authors:  Iris Crespo; Alicia Santos; Elena Valassi; Patricia Pires; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2015-05-28       Impact factor: 3.633

Review 4.  Pituitary disease mortality: is it fiction?

Authors:  Eva Marie Erfurth; Peter Siesjö; Thomas Björk-Eriksson
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

Review 5.  STEREOTACTIC RADIATION THERAPY IN PITUITARY ADENOMAS, IS IT BETTER THAN CONVENTIONAL RADIATION THERAPY?

Authors:  M L Gheorghiu; M Fleseriu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

6.  Physical activity, cognitive function, and brain health: what is the role of exercise training in the prevention of dementia?

Authors:  Sara M Gregory; Beth Parker; Paul D Thompson
Journal:  Brain Sci       Date:  2012-11-29

7.  Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer.

Authors:  Huaidong Cheng; Haijun Chen; Yue Lv; Zhendong Chen; Chiang-Shan R Li
Journal:  Cancer Med       Date:  2018-09-27       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.